Why Are HSV-1 Antiviral Medications So Hard to Find? [Explained for 2026]

If you've ever walked into a pharmacy to pick up acyclovir or valacyclovir — the two most commonly prescribed antivirals for herpes simplex virus type 1 (HSV-1) — and been told it's out of stock, you're not alone. Millions of patients across the United States face the same frustrating experience every year. In this guide, we break down exactly why HSV-1 antiviral medications are so hard to find, what's driving shortages, and what you can do about it in 2026.

What Are HSV-1 Antiviral Medications?

HSV-1 (herpes simplex virus type 1) infects an estimated 3.7 billion people under the age of 50 worldwide — roughly 67% of the global population. In the United States alone, there were approximately 7.4 million diagnosed HSV-1 cases in 2024. The virus causes cold sores (herpes labialis), genital herpes (increasingly attributed to HSV-1), and in severe cases, herpes simplex encephalitis.

The three primary antiviral medications used to treat HSV-1 are:

• Acyclovir (Zovirax) — the original antiviral, available in oral, topical, and IV formulations
• Valacyclovir (Valtrex) — a prodrug of acyclovir with 3–5x better oral bioavailability and more convenient dosing
• Famciclovir (Famvir) — a prodrug of penciclovir, effective for HSV-1 and HSV-2

All three are FDA-approved and available in generic form. None are controlled substances.

Why Is IV Acyclovir Especially Hard to Find?

The intravenous (IV) form of acyclovir has been experiencing intermittent shortages since 2020. The shortage began with manufacturing disruptions during the COVID-19 pandemic and has continued due to sustained demand increases. Here's why:

• Low profit margins: Acyclovir is an older, off-patent generic medication. Manufacturing costs have risen, but prices remain low — making it unattractive for manufacturers to invest in production capacity.
• Concentrated manufacturing: Only a few manufacturers produce IV acyclovir in the U.S. When one has a production issue, the entire supply chain is affected.
• Rising prescription volume: The number of acyclovir prescriptions has been climbing steadily, driven by better HSV awareness, growing use of daily suppressive therapy, and more testing.
• Uneven distribution: Even when adequate supply exists nationally, large chain pharmacies may receive priority allocations from wholesalers, leaving smaller or rural pharmacies understocked.

What About Oral Acyclovir and Valacyclovir?

Oral forms of HSV-1 antivirals — tablets, capsules, and oral suspension — are generally available at most pharmacies in 2026. However, individual pharmacies may temporarily run out due to uneven distribution and high demand. If your local CVS, Walgreens, or Rite Aid is out of stock, another pharmacy nearby may have it.

The key insight: the shortage is localized and inconsistent. National supply may be adequate while your specific ZIP code experiences a temporary gap. This is exactly the problem that medfinder was built to solve — calling pharmacies near you to check which ones actually have your medication in stock.

How the HSV-1 Shortage Affects Different Patient Groups

Not all HSV-1 patients are equally affected by availability challenges:

• Suppressive therapy patients: Those taking antivirals daily to prevent outbreaks are most vulnerable, as they can't simply skip a dose. Running out of medication interrupts protection.
• Immunocompromised patients: Transplant recipients, HIV patients, and chemotherapy patients rely heavily on IV acyclovir for severe HSV infections. The IV shortage poses the greatest risk to this group.
• Episodic treatment patients: Those who only take antivirals during outbreaks may find it harder to start treatment quickly if the pharmacy is out of stock — and timing is critical for antivirals to be effective.

Is the HSV-1 Antiviral Shortage Getting Better or Worse in 2026?

The situation in 2026 is mixed. The IV acyclovir shortage continues but is gradually improving as manufacturers have increased production. Oral acyclovir, valacyclovir, and famciclovir are widely available at the national level, though spot shortages at individual pharmacies still occur. Patients on suppressive therapy are generally able to fill their prescriptions with a little searching.

The best approach is to stay proactive: refill prescriptions 5–7 days before running out, call ahead to confirm stock, or use a service like medfinder to quickly locate pharmacies with your medication in stock.

What Can You Do If Your HSV-1 Medication Is Out of Stock?

If you can't find acyclovir or valacyclovir at your usual pharmacy, here are immediate steps to take:

1. Use medfinder to quickly find which pharmacies near you have your antiviral in stock, without calling each one yourself.
2. Ask about switching formulations. If acyclovir 400 mg is out of stock, the 800 mg tablet may be available (which can be split). Ask your pharmacist.
3. Ask your doctor about switching to valacyclovir or famciclovir — both treat the same HSV-1 infections and are often in stock when acyclovir is not.
4. Try mail-order pharmacies like Cost Plus Drugs, Amazon Pharmacy, or Honeybee Health, which often maintain better stock of generic medications.
5. Check multiple pharmacies — chain pharmacies, independent pharmacies, and grocery store pharmacies often have different stock levels.

The Bottom Line

HSV-1 antiviral medications aren't hard to find because they're rare — they're hard to find because demand is high and distribution is uneven. The good news is that with the right tools, most patients can fill their prescriptions without much delay. Use medfinder to locate pharmacies near you with stock in hand. And if your usual medication is unavailable, read our guide on how to find HSV-1 antivirals in stock or explore alternatives to HSV-1 antivirals if you can't fill your prescription.